Next Generation Drug Conjugates Market Worth USD 7 94 Billion to 2031 - Exclusive Report by InsightAce Analytic Pvt Ltd prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
The Peptide Receptor Radionuclide Therapy (PRRT) Industry is on a trajectory of exceptional growth, with projections indicating a worth of US$ 591.83 million in 2023 and a substantial leap towards US$ 1,300 million by 2033. This robust expansion is driven by a promising Compound Annual Growth Rate (CAGR) of 8.2% exp.
During the forecast period, the peptide receptor radionuclide therapy (prrt) market is expected to grow at a strong CAGR of 7.2%. The market is currently worth US$ 552.08 million in 2022 and is expected to grow by US$ 1,106.50 million by 2032.This Peptide Receptor Radionuclide Therapy market study offers a comprehen.